查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1988474

主动脉瘤市场：2026-2032年全球市场预测（按类型、治疗方法、器材类型、适应症、患者年龄层、性别和最终用户划分）

Aortic Aneurysm Market by Aneurysm Type, Treatment Modality, Device Type, Indication, Patient Age Group, Gender, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，主动脉瘤市场价值将达到 52.2 亿美元，到 2026 年将成长至 56.9 亿美元，到 2032 年将达到 96.3 亿美元，复合年增长率为 9.14%。

主要市场统计数据
基准年 2025 52.2亿美元
预计年份：2026年 56.9亿美元
预测年份 2032 96.3亿美元
复合年增长率 (%) 9.14%

本导言部分概述了影响主动脉瘤治疗和相关人员决策的临床实践、技术和医疗保健服务的发展趋势。

主动脉瘤的治疗正处于外科创新、人口结构变化和医疗服务模式演变的交汇点。近年来，临床实务稳步转向微创治疗，同时影像学和医疗设备技术也取得了长足进步，使得降低围手术全期风险变得日益重要。这些趋势与人口老化和心血管合併症负担日益加重的背景下交织在一起，既造成了持续的临床需求，也使得人们更加关注安全、长期有效且经济的治疗方案。

对临床创新、医疗服务格局的转变以及监管重点如何重塑所有相关人员。

由于技术成熟、医疗服务环境转变以及相关人员价值观的重新定义，主动脉瘤的治疗现状正在经历一场变革。微创血管内修復术，得益于影像精度的提高、导航系统的改进以及可治疗以往无法手术部位的模组化血管支架的设计，已从一种小众选择发展成为多种解剖类型主动脉瘤的标准治疗方案。这些进步辅以术前术后优化技术和促进復原的通讯协定，从而缩短了住院时间并减少了术后併发症，进而改变了临床决策的标准。

详细分析 2025 年美国关税变化将如何影响整个主动脉瘤治疗生态系统中医疗设备的采购、製造策略和购买决策。

美国于2025年实施的关税调整，为参与主动脉瘤治疗的医疗设备製造商、医疗系统和经销商的供应链计算引入了新的变数。许多用于血管内和开放式手术修復的医疗设备和组件都来自世界各地，进口关税的变化可能导致血管支架移植物、人工血管及相关输送组件的总体成本增加。这些成本压力会波及整个采购流程，迫使医院供应链团队重新谈判合约、重新评估供应商多元化策略，并考虑某些生产和灭菌流程在地化的可行性。

透过细分主导洞察，将治疗方法、解剖复杂性、医疗保健环境和患者人口统计数据联繫起来，从而指导可操作的临床和商业策略。

细分市场分析揭示了影响治疗方法选择、医疗设备需求和医疗机构采纳的清晰临床路径和商业性考虑。基于治疗方法，临床医生会将血管内修復与开放手术修復进行比较，并考虑患者的解剖结构和生理耐受力。在血管内技术中，配备先进输送平台的血管支架系统正被越来越多地用于扩大应用范围；而在开放手术修復中，生物导管和合成血管移植物仍然被广泛使用，其耐久性和特定的解剖结构要求决定了手术方式的选择。

区域评估突显了医疗保健基础设施、报销制度和临床实践的差异如何影响全球主要地区的主动脉瘤治疗。

区域趋势导致临床实践、基础设施建设和监管预期存在显着差异，进而影响主动脉瘤治疗的实施方式和产品的商业化。在美洲，微创手术备受推崇，并拥有完善的公共和私人医疗保险体系。先进的影像网路和高容量的三级医疗机构支援新型血管内移植物和复杂开窗解决方案的快速应用，而低风险、选择性的手术病例也逐渐在门诊环境中得到认可。

从产业角度概述创新管道、供应链敏捷性和证据产生如何塑造医疗设备製造商之间的竞争差异化。

主动脉瘤领域的企业策略着重于持续创新、临床证据的累积和营运规模的扩大。领先的医疗设备开发商正优先投资于新一代血管支架结构、低轮廓输送系统和材料科学，以改善长期治疗效果并扩大其解剖学适用范围。医疗设备创新者与契约製造和影像技术公司之间的策略合作日益普遍，从而能够提供植入性能与先进导航和术中成像相结合的整合解决方案。

为协调产品开发、供应链韧性和基于价值的商业化，以加速产品推广和临床应用，提出切实可行的策略建议。

产业领导者应采取多管齐下的策略，使产品创新与医疗服务趋势、监管预期和采购实际情况相契合。首先，他们应优先发展模组化、解剖结构适应性强的器材平台，以降低手术复杂性，扩大微创治疗的适用人群，从而促进其在各种医疗环境中的广泛应用。其次，他们应投资于可靠的真实世界数据（REW）收集和註册系统，以加快保险公司的接受度，证明产品的长期安全性，并根据临床实际情况推动产品的迭代改进。

对用于获取有关主动脉瘤治疗的临床、商业性和供应链见解的定性和定量调查方法的整合进行透明的解释。

本执行摘要的调查方法融合了定性和定量方法，以确保得出严谨且基于证据的见解。主要资讯来源包括对血管外科医生、介入医生、医院采购经理和医疗设备监管专家的访谈，以了解目前的临床实践、医疗设备选择标准以及推广应用的障碍。除了这些临床层面的观点外，与供应链和商业领导者的讨论也提供了关于生产製造方面的考虑、分销趋势以及近期贸易政策影响的见解。

简洁结论总结了临床创新、供应链趋势和策略挑战之间的相互作用，这些因素将决定主动脉瘤治疗的未来成功。

主动脉瘤治疗正处于一个转折点，技术创新、人口压力和不断变化的医疗模式相互交织，为临床医生、製造商和医疗系统带来了机会和挑战。微创血管内治疗策略的兴起扩大了可治疗疾病的范围，并改变了资源分配，而器械开发商则透过针对性的创新来应对解剖学挑战并提高器械的长期耐用性。同时，包括贸易发展和保险公司审查在内的商业性和政策趋势，也影响筹资策略和市场准入方式。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：主动脉瘤市场：依动脉瘤类型划分

  • 腹部主动脉血管瘤
    • 下肾
    • 肾旁
    • 肾上腺上部
  • 胸主动脉瘤
    • 上升部分
    • 下降部分
    • 胸部 腹部

第九章 主动脉瘤市场：依治疗方法

  • 血管内修復
  • 透过开放式手术进行修復
    • 生物血管移植物
    • 人工血管移植

第十章：主动脉瘤市场：依器材类型划分

  • 血管支架
  • 人工血管移植

第十一章：主动脉瘤市场：依适应症划分

  • 已安排的手术
  • 爆裂修復

第十二章：主动脉瘤市场：依病患年龄组别划分

  • 65岁或以上
  • 65岁以下

第十三章 主动脉瘤市场：性别

  • 女士
  • 男性

第十四章 主动脉瘤市场：依最终用户划分

  • 门诊手术中心
    • 循环系统中心
    • 独立外科中心
  • 医院
    • 综合医院
    • 血管专科中心
    • 三级医疗医院

第十五章：主动脉瘤市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十六章 主动脉瘤市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十七章 主动脉瘤市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十八章：美国：主动脉瘤市场

第十九章 中国：主动脉瘤市场

第20章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Altura Medical Inc.
  • Artivion, Inc.
  • Bentley InnoMed GmbH
  • Bolton Medical, Inc.
  • Boston Scientific Corporation
  • Cardinal Health company
  • Cook Medical Inc.
  • CryoLife, Inc.
  • Endologix Inc.
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips NV
  • Lemaitre Vascular Inc.
  • LifeTech Scientific Corporation
  • LivaNova PLC
  • Lombard Medical, Inc.
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Phenox GmbH
  • Terumo Corporation
  • WL Gore & Associates, Inc.
Product Code: MRR-D1342F184FD2

The Aortic Aneurysm Market was valued at USD 5.22 billion in 2025 and is projected to grow to USD 5.69 billion in 2026, with a CAGR of 9.14%, reaching USD 9.63 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.22 billion
Estimated Year [2026] USD 5.69 billion
Forecast Year [2032] USD 9.63 billion
CAGR (%) 9.14%

An overarching introduction that frames the evolving clinical, technological, and delivery dynamics shaping aortic aneurysm treatment and stakeholder decision-making

Aortic aneurysm management sits at the intersection of surgical innovation, demographic shifts, and evolving healthcare delivery models. Recent years have seen the steady migration of clinical preference toward less invasive therapies, concurrent advances in imaging and device technology, and a heightened emphasis on perioperative risk mitigation. These dynamics converge against a backdrop of an ageing population with rising cardiovascular comorbidity burden, creating sustained clinical demand while simultaneously intensifying the focus on safety, long-term durability, and cost-effective pathways for intervention.

Clinicians and health system leaders are now navigating a more complex therapeutic landscape in which endovascular options must be balanced against open repair approaches based on anatomical suitability, patient frailty, and access-to-care considerations. Device designers are responding with increasingly sophisticated stent graft architectures, refined delivery systems, and adjunctive tools to address challenging anatomies such as short-necked infrarenal aneurysms and complex thoracoabdominal lesions. At the same time, payors and hospital administrators are scrutinizing procedural site selection and resource utilization, prompting closer evaluation of ambulatory surgery centers and streamlined care protocols.

This executive summary synthesizes current clinical trends, regulatory and commercial shifts, and provider-level strategic implications to support clinicians, manufacturers, and investors in making informed decisions. The analysis emphasizes actionable insights into modality choice, device differentiation, end-user adoption patterns, and regional variations that are shaping the path forward for aortic aneurysm care.

An in-depth analysis of how clinical innovation, care setting transitions, and regulatory emphasis are reshaping aortic aneurysm treatment paradigms across stakeholders

The landscape of aortic aneurysm care is undergoing transformative shifts driven by technological maturation, changing care settings, and the reframing of value across stakeholders. Minimally invasive endovascular repair has progressed from a niche alternative to a default option for many anatomies, supported by improved imaging fidelity, navigation systems, and modular stent graft designs that address previously inoperable segments. These advances are complemented by perioperative optimization techniques and enhanced recovery protocols that reduce length of stay and procedural morbidity, thereby altering the calculus of clinical decision-making.

Concurrently, device innovation is moving toward personalized solutions, including fenestrated and branched endografts, low-profile delivery systems, and materials engineered for long-term durability and reduced thrombogenicity. These innovations expand candidacy for endovascular approaches, particularly among older or comorbid patients who would face higher risks with open surgical repair. The shift is not purely technological; it reflects an ecosystem change where multidisciplinary teams, including vascular surgery, interventional radiology, and cardiac surgery, increasingly collaborate to tailor therapy to patient-specific anatomy and risk profiles.

Health systems are also redefining care pathways, directing lower-risk elective procedures to ambulatory settings and employing telemedicine and remote monitoring for follow-up surveillance. This decentralization of care pressures device manufacturers to standardize training, simplify deployment, and ensure consistent outcomes across disparate settings. Lastly, regulatory emphasis on post-market surveillance and real-world evidence is prompting companies to invest in registries and longitudinal studies, which in turn inform clinical guidelines and payer coverage policies. Together, these shifts create both opportunity and competitive pressure for stakeholders to adapt strategy, investment, and product development roadmaps.

A detailed exploration of how the 2025 United States tariff changes have influenced device sourcing, manufacturing strategies, and procurement decisions across the aortic aneurysm ecosystem

Tariff adjustments implemented in the United States in 2025 introduced a new variable into the supply chain calculus for medical device manufacturers, health systems, and distributors involved in aortic aneurysm care. Many devices and components used in endovascular and open surgical repairs are sourced globally, and changes in import duties can result in increased landed costs for stent grafts, synthetic conduits, and ancillary delivery components. These cost pressures ripple through procurement processes, prompting hospital supply chain teams to renegotiate contracts, reassess supplier diversification strategies, and evaluate the feasibility of localizing certain manufacturing or sterilization processes.

The cumulative impact of the tariff measures has prompted manufacturers to reassess their global sourcing footprints, with some prioritizing regional production hubs to mitigate exposure to trade fluctuations. For devices that rely on specialized raw materials or implants produced by a limited set of suppliers, tariffs have amplified the need for transparent cost structures and contingency planning. Health systems facing constrained operating budgets may respond by enhancing value-based contracting, extending device reuse policies within regulatory allowances, or prioritizing procedural modalities that demonstrate stronger cost-effectiveness in their local contexts.

Regulatory and reimbursement bodies have also taken notice, and the interplay between import duties and pricing has the potential to alter negotiations around bundled payments and procedural reimbursement. For international suppliers, tariff-induced pricing changes may slow market entry or shift commercialization timelines, particularly for high-complexity devices that require substantial clinical evidence prior to adoption. Ultimately, the 2025 tariff environment underscores the importance of supply-chain resilience, flexible manufacturing strategies, and closer collaboration between manufacturers and providers to preserve access to life-saving aortic aneurysm interventions while managing economic impacts.

Segment-driven insights that connect treatment modalities, anatomical complexity, care settings, and patient demographics to actionable clinical and commercial strategies

Segmentation analysis reveals distinct clinical pathways and commercial considerations that influence treatment selection, device demand, and provider adoption. Based on treatment modality, clinicians weigh endovascular repair against open surgical repair by considering patient anatomy and physiological resilience; endovascular techniques increasingly leverage stent graft systems with advanced delivery platforms to expand applicability, while open surgical repair continues to rely on both biological conduits and synthetic vascular grafts where durability and specific anatomical requirements dictate approach.

When viewed through the lens of aneurysm type, abdominal aortic aneurysms and thoracic aortic aneurysms present different technical challenges and device requirements. Abdominal presentations are further stratified by infrarenal, juxtarenal, and suprarenal locations, each demanding unique fixation and sealing strategies, whereas thoracic presentations span ascending, descending, and thoracoabdominal segments that often require branched or fenestrated designs to preserve branch vessel integrity. These anatomical distinctions drive product development priorities, imaging protocols, and operator training needs.

End-user segmentation highlights divergent adoption curves and procedural settings. Ambulatory surgery centers, including cardiology-centered facilities and standalone surgery centers, are increasingly attractive for lower-risk, elective interventions that benefit from streamlined throughput and lower overhead. Conversely, hospitals, whether general, specialized vascular centers, or tertiary care institutions, maintain primacy for high-complexity cases and ruptured presentations that require multidisciplinary resources and critical care capabilities.

Device type segmentation isolates stent graft systems and synthetic vascular grafts as core product categories, each with unique regulatory pathways, sterilization requirements, and surgeon preferences. Indication-based segmentation differentiates elective repairs, where optimization of recovery and cost containment are priorities, from rupture repairs, which demand immediate access to robust devices and emergent care pathways. Patient demographics further nuance demand patterns, with an older cohort driving higher procedural volume and anatomical complexity; gender differences shape risk stratification and anatomical fit considerations, necessitating inclusive design and evidence generation across populations.

A regional assessment highlighting how divergent healthcare infrastructures, reimbursement approaches, and clinical practices shape aortic aneurysm care across major global geographies

Regional dynamics produce meaningful variation in clinical practice, infrastructure readiness, and regulatory expectations that affect how aortic aneurysm care is delivered and how products are commercialized. In the Americas, there is a strong emphasis on minimally invasive approaches coupled with robust private and public payer systems; advanced imaging networks and high-volume tertiary centers support rapid adoption of novel endografts and complex fenestrated solutions, while ambulatory settings are progressively absorbing lower-risk elective cases.

Europe, Middle East & Africa present a heterogeneous landscape where western European markets emphasize guideline-driven adoption and centralized specialized vascular centers, and emerging markets across the Middle East and Africa grapple with infrastructure constraints and variable access to advanced devices. Regulatory alignment with regional authorities and investments in training and centers of excellence are critical to expanding reach across these diverse healthcare systems.

Asia-Pacific demonstrates accelerated uptake in innovation in several urbanized markets that combine high procedure volumes with expanding ambulatory infrastructures. Local manufacturing capacities and partnerships with global manufacturers are shaping access and price dynamics, while demographic trends and public health initiatives are increasing screening and early detection efforts. Across regions, differences in reimbursement structures, clinical guideline adoption, and workforce availability create distinct strategic imperatives for manufacturers and providers seeking sustainable growth and clinical impact.

An industry-focused overview of how innovation pipelines, supply chain agility, and evidence generation are shaping competitive differentiation among device manufacturers

Corporate strategy in the aortic aneurysm domain centers on sustained innovation, clinical evidence generation, and operational scale. Leading device developers prioritize investments in next-generation stent graft architectures, low-profile delivery systems, and materials science to improve long-term outcomes and broaden anatomical applicability. Strategic alliances between device innovators and contract manufacturers or imaging technology firms are increasingly common, enabling integrated solutions that combine implant performance with advanced navigation and intraoperative imaging.

Investment in post-market surveillance and real-world data initiatives has become a differentiator, supporting regulatory submissions, payer negotiations, and clinician confidence. Firms that can demonstrate comprehensive training programs, robust customer support, and streamlined logistics achieve higher penetration across ambulatory and hospital settings. Meanwhile, smaller and emerging medtech companies focus on niche innovations-such as branched configurations for complex thoracoabdominal repairs or biologically optimized graft materials-positioning themselves for acquisition or strategic partnerships with larger players.

Supply-chain agility and regional manufacturing presence influence competitive positioning, particularly in areas affected by trade policy shifts. Companies that proactively localize production or diversify supplier networks reduce exposure to tariff volatility and distribution bottlenecks. Additionally, those that invest in digital tools for follow-up surveillance, patient-reported outcomes, and remote monitoring create differentiated value propositions for health systems prioritizing longitudinal care and cost containment.

Actionable strategic recommendations that align product development, supply chain resilience, and value-based commercialization to accelerate adoption and clinical impact

Industry leaders should adopt a multi-pronged strategy that aligns product innovation with care delivery trends, regulatory expectations, and procurement realities. First, prioritize modular and anatomically adaptable device platforms that reduce procedure complexity and expand the pool of patients eligible for less invasive treatment, thereby enabling broader adoption across diverse care settings. Second, invest in robust real-world evidence generation and registries to accelerate payer acceptance, validate long-term safety, and inform iterative product improvements that are grounded in clinical practice realities.

Third, strengthen supply-chain resilience by diversifying supplier bases, exploring regional production hubs, and developing contingency plans for component sourcing to mitigate the impact of trade policy shifts. Fourth, tailor commercial approaches to end-user segmentation by offering targeted training and support programs for ambulatory surgery centers, and by providing integrated clinical pathways for tertiary hospitals managing complex rupture cases. Fifth, collaborate with health systems to pilot bundled-care models and outcome-based contracts that align reimbursement with value delivered, thus improving access while demonstrating cost-effectiveness.

Finally, foster multidisciplinary clinician engagement and invest in education that promotes appropriate patient selection, surveillance protocols, and secondary prevention; this clinician-centric approach supports safer adoption of novel devices and strengthens long-term patient outcomes. These combined actions will position organizations to capture clinical and commercial opportunities while managing operational risks.

A transparent explanation of the blended qualitative and quantitative research approach used to derive clinical, commercial, and supply chain insights for aortic aneurysm care

The research methodology underpinning this executive summary integrates qualitative and quantitative approaches to ensure rigorous, evidence-based insights. Primary inputs include expert interviews with vascular surgeons, interventionalists, hospital procurement leaders, and device regulatory specialists to capture current clinical practice, device preferences, and adoption barriers. These clinician-level perspectives are supplemented by discussions with supply-chain and commercial leaders to understand manufacturing considerations, distribution dynamics, and the implications of recent trade policies.

Secondary research involved a systematic review of peer-reviewed clinical literature, regulatory guidance documents, and professional society position statements to validate clinical trends and device-specific performance characteristics. Where appropriate, registry data and published post-market surveillance reports were analyzed to assess safety signals and durability considerations, and findings were triangulated across multiple sources to enhance robustness. The segmentation framework was applied to map product types, indications, end-user settings, and patient cohorts to ensure that insights reflect the diversity of clinical pathways and commercial channels.

Finally, analytic rigor was maintained through cross-validation of thematic findings with independent experts and iterative refinement of conclusions to reflect both clinical nuance and commercial realism. This blended methodology supports actionable recommendations while acknowledging areas where evidence remains emergent and where ongoing surveillance will be required.

A concise conclusion summarizing the interplay of clinical innovation, supply chain dynamics, and strategic imperatives that will determine future success in aortic aneurysm care

Aortic aneurysm care is at an inflection point where technological innovation, demographic pressures, and changing care models intersect to create both opportunity and complexity for clinicians, manufacturers, and health systems. The move toward minimally invasive endovascular strategies is broadening treatment candidacy and shifting resource allocation, while device developers respond with targeted innovations that address anatomical challenges and long-term durability. At the same time, commercial and policy developments, including trade dynamics and payer scrutiny, are influencing procurement strategies and go-to-market approaches.

Stakeholders that align product development with clinical evidence, invest in training and post-market surveillance, and build resilient supply chains will be best positioned to deliver patient-centered outcomes while achieving sustainable commercial performance. Embracing collaborative models with health systems and payers that emphasize value and outcomes will further enable access to advanced therapies and support the long-term viability of innovative solutions. As the landscape continues to evolve, continued monitoring of clinical data, regulatory developments, and regional care models will be essential to refine strategies and maintain alignment with emerging best practices.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Aortic Aneurysm Market, by Aneurysm Type

  • 8.1. Abdominal Aortic Aneurysm
    • 8.1.1. Infrarenal
    • 8.1.2. Juxtarenal
    • 8.1.3. Suprarenal
  • 8.2. Thoracic Aortic Aneurysm
    • 8.2.1. Ascending
    • 8.2.2. Descending
    • 8.2.3. Thoracoabdominal

9. Aortic Aneurysm Market, by Treatment Modality

  • 9.1. Endovascular Repair
  • 9.2. Open Surgical Repair
    • 9.2.1. Biological Conduit
    • 9.2.2. Synthetic Vascular Graft

10. Aortic Aneurysm Market, by Device Type

  • 10.1. Stent Graft
  • 10.2. Synthetic Vascular Graft

11. Aortic Aneurysm Market, by Indication

  • 11.1. Elective Repair
  • 11.2. Rupture Repair

12. Aortic Aneurysm Market, by Patient Age Group

  • 12.1. 65 And Above
  • 12.2. Under 65

13. Aortic Aneurysm Market, by Gender

  • 13.1. Female
  • 13.2. Male

14. Aortic Aneurysm Market, by End User

  • 14.1. Ambulatory Surgery Centers
    • 14.1.1. Cardiology Centers
    • 14.1.2. Standalone Surgery Centers
  • 14.2. Hospitals
    • 14.2.1. General Hospitals
    • 14.2.2. Specialized Vascular Centers
    • 14.2.3. Tertiary Care Hospitals

15. Aortic Aneurysm Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Aortic Aneurysm Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Aortic Aneurysm Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Aortic Aneurysm Market

19. China Aortic Aneurysm Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Abbott Laboratories
  • 20.6. Altura Medical Inc.
  • 20.7. Artivion, Inc.
  • 20.8. Bentley InnoMed GmbH
  • 20.9. Bolton Medical, Inc.
  • 20.10. Boston Scientific Corporation
  • 20.11. Cardinal Health company
  • 20.12. Cook Medical Inc.
  • 20.13. CryoLife, Inc.
  • 20.14. Endologix Inc.
  • 20.15. Johnson & Johnson Services, Inc.
  • 20.16. Koninklijke Philips N.V.
  • 20.17. Lemaitre Vascular Inc.
  • 20.18. LifeTech Scientific Corporation
  • 20.19. LivaNova PLC
  • 20.20. Lombard Medical, Inc.
  • 20.21. Medtronic PLC
  • 20.22. MicroPort Scientific Corporation
  • 20.23. Phenox GmbH
  • 20.24. Terumo Corporation
  • 20.25. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL AORTIC ANEURYSM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL AORTIC ANEURYSM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL AORTIC ANEURYSM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES AORTIC ANEURYSM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA AORTIC ANEURYSM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL AORTIC ANEURYSM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY INFRARENAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY INFRARENAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY INFRARENAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY JUXTARENAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY JUXTARENAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY JUXTARENAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SUPRARENAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SUPRARENAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SUPRARENAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ASCENDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ASCENDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ASCENDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY DESCENDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY DESCENDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY DESCENDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACOABDOMINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACOABDOMINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACOABDOMINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY BIOLOGICAL CONDUIT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY BIOLOGICAL CONDUIT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY BIOLOGICAL CONDUIT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SYNTHETIC VASCULAR GRAFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SYNTHETIC VASCULAR GRAFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SYNTHETIC VASCULAR GRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STENT GRAFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STENT GRAFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STENT GRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SYNTHETIC VASCULAR GRAFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SYNTHETIC VASCULAR GRAFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SYNTHETIC VASCULAR GRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ELECTIVE REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ELECTIVE REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ELECTIVE REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY RUPTURE REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY RUPTURE REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY RUPTURE REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY 65 AND ABOVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY 65 AND ABOVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY 65 AND ABOVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY UNDER 65, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY UNDER 65, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY UNDER 65, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY FEMALE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY FEMALE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY FEMALE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY MALE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY MALE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY MALE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY CARDIOLOGY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY CARDIOLOGY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY CARDIOLOGY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STANDALONE SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STANDALONE SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STANDALONE SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SPECIALIZED VASCULAR CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SPECIALIZED VASCULAR CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SPECIALIZED VASCULAR CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 214. GCC AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 215. GCC AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. GCC AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 217. GCC AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 218. GCC AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 219. GCC AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2032 (USD MILLION)
  • TABLE 220. GCC AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. GCC AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 222. GCC AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 223. GCC AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 224. GCC AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. GCC AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 226. GCC AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPEAN UNION AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 248. BRICS AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 253. G7 AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 254. G7 AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. G7 AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 256. G7 AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 257. G7 AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 258. G7 AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2032 (USD MILLION)
  • TABLE 259. G7 AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. G7 AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 261. G7 AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 262. G7 AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 263. G7 AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 264. G7 AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 265. G7 AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 266. NATO AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 267. NATO AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. NATO AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 269. NATO AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 270. NATO AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 271. NATO AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2032 (USD MILLION)
  • TABLE 272. NATO AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. NATO AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 274. NATO AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 275. NATO AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 276. NATO AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 277. NATO AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 278. NATO AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 279. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES AORTIC ANEURYSM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 292. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 293. CHINA AORTIC ANEURYSM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 294. CHINA AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. CHINA AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 296. CHINA AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 297. CHINA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 298. CHINA AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2032 (USD MILLION)
  • TABLE 299. CHINA AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 300. CHINA AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 301. CHINA AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 302. CHINA AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 303. CHINA AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 304. CHINA AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 305. CHINA AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)